Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07307989
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07307989
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Recruiting
Technical summary
Registry record NCT07307989. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2029-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
- Condition
- Ischemic Stroke
- Condition
- Hypercholesteremia
- Intervention (Drug)
- statin + ezetimibe
- Intervention (Drug)
- Statin monotherapy (rosuvastatin or atorvastatin)
- Lead sponsor
- Chang Gung Memorial Hospital
- Collaborator
- Chang Gung University
Record details
- Record id
cardio:ct-nct07307989- Content hash
b61e762663e7c223ff48e154695008608925ece746cb7629ed2957066d3d717b